Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
The Progressive Corporation (PGR) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Progressive Corporation (PGR) - free report >>
Image: Shutterstock
Best Momentum Stocks to Buy for October 27th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 27:
Vertiv Holdings Co (VRT - Free Report) : This digital infrastructure solutions provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
Vertiv Holdings Co. Price and Consensus
Vertiv Holdings Co. price-consensus-chart | Vertiv Holdings Co. Quote
Vertiv Holdings’ shares gained 34.3% over the last three months compared with the S&P 500’s decline of 8.2%. The company possesses a Momentum Score of A.
Vertiv Holdings Co. Price
Vertiv Holdings Co. price | Vertiv Holdings Co. Quote
The Progressive Corporation (PGR - Free Report) : This insurance holding company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.3% over the last 60 days.
The Progressive Corporation Price and Consensus
The Progressive Corporation price-consensus-chart | The Progressive Corporation Quote
The Progressive’s shares gained 23.1% over the last three months compared with the S&P 500’s decline of 8.2%. The company possesses a Momentum Score of A.
The Progressive Corporation Price
The Progressive Corporation price | The Progressive Corporation Quote
Can-Fite BioPharma Ltd. (CANF - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.3% over the last 60 days.
Can-Fite Biopharma Ltd Price and Consensus
Can-Fite Biopharma Ltd price-consensus-chart | Can-Fite Biopharma Ltd Quote
Can-Fite BioPharma’s shares gained 9.2% over the last six months compared with the S&P 500’s advance of 1.4%. The company possesses a Momentum Score of A.
Can-Fite Biopharma Ltd Price
Can-Fite Biopharma Ltd price | Can-Fite Biopharma Ltd Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.